by Hans R. Larsen, MSc ChE

Read the entire article at: http://www.yourhealthbase.com/lipoic_acid.htm

Alpha-lipoic acid, also known as thioctic acid, is the newest kid on the antioxidant block. Alpha-lipoic acid (ALA) was first isolated in 1953 and was quickly discovered to be a very important cofactor in the Krebs cycle (citric acid cycle), the body's main process for converting carbohydrates into energy. ALA is a medium length (8 carbon atoms) fatty acid containing two sulfur atoms. It is readily synthesized in the body and is well absorbed from the diet through the stomach and intestines. Liver and yeast are especially good dietary sources of ALA. ALA is the oxidized form of dihydrolipoic acid (DHLA), is water-soluble, and is found in varying concentrations in all muscles and internal organs(1,2).

In 1959 it was discovered that both ALA and DHLA are powerful antioxidants. ALA scavenges hydroxyl radicals, singlet oxygen and hypochlorous acid, can remove heavy metals by chelation and regenerates other antioxidants like glutathione, vitamin C, ubiquinol (coenzyme Q10) and indirectly, vitamin E. DHLA has similar properties(1).

Researchers have found that administration of ALA (intravenously or orally) is effective in alleviating many of the problems accompanying diabetes. Animal experiments have shown that ALA can prevent the development of Type I (insulin-dependent) diabetes and enhances glucose uptake in Type II (non- insulin-dependent) diabetes. A recent clinical trial showed that intravenous administration of ALA (200 mg/day) for 21 days markedly reduces the pain caused by polyneuropathy (peripheral nerve disease) in diabetes patients(3). Another larger study of diabetics with polyneuropathy involved intravenous injection of 600 mg/day of ALA for three weeks followed by 12 weeks of oral supplementation (600 mg/day). Marked pain reduction was again evident and ALA is now approved in Germany for the treatment of diabetes neuropathy(1,4). Experiments have also shown that ALA supplementation can reduce the risk of cataract formation in diabetics(5-7). Diabetics taking ALA need close monitoring of their blood sugar levels as ALA supplementation may decrease the need for insulin and other drugs(2).

Heart attacks and strokes involve a disruption of the oxygen supply to the affected areas. When the oxygen supply is restored a burst of free radicals is produced which can cause additional tissue damage (ischemia-reperfusion injury). Animal experiments have shown that ALA and DHLA are effective in preventing or ameliorating ischemia-reperfusion injury(1).

HIV-infected patients are often antioxidant deficient and many researchers believe that oxidative stress (free radical reactions) play a major role in the initiation and progression of HIV infection and AIDS(8-10). Some very recent experiments have shown that ALA supplementation (150 mg three times per day) is effective in restoring antioxidant status in HIV patients(11). Oxidative stress also plays a major role in the development and progression of neurodegenerative diseases such as Alzheimer's and Parkinson's. Animal experiments have shown that ALA supplementation can reverse age-related memory loss and there is some evidence that ALA may be useful in the treatment of epilepsy(12,13).

A very recent study of children living in the area affected by the Chernobyl disaster showed that ALA prevents radiation damage(14). There is also evidence that ALA could play a role in minimizing the adverse effects of smoking and may be useful in the treatment of mercury and cadmium poisoning